gilteritinib

Ukraine

Drugs containing this active substance

  • KSOSPATA

    The drug is intended for monotherapy in adult patients with relapsed or refractory acute myeloid leukemia (AML) with a confirmed FLT3 mutation.

    Form: tablets, film-coated

    Active substance Dosage
    gilteritinib 40 mg

    ATC: L01EX13

    Manufacturer: Delpharm Meppel B.V. (primary packaging, secondary packaging, quality control, batch release)